• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 2.25/22; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 2.25/22; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 364499
Medical Device Problem Code Failure to Advance (2524)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 11/16/2019
Type of Reportable Event Malfunction
Event or Problem Description
The orsiro drug-eluting stent system was selected to treat a severely calcified and tortuous lesion in the proximal lad.After pre-dilatation the target lesion could not be crossed.
 
Additional Manufacturer Narrative
The affected product was discarded at the hospital due to an infectious disease.Therefore no technical investigation on the device could be performed.The production documentation of the product was reviewed to determine whether there was any deviation that could account for this event.Further, the provided angiographic material was reviewed.The provided angiographic material was reviewed, but the actual complaint event is not visible.The presence of a severe calcification and tortuosity could be confirmed.Review of the production documentation of the complaint device confirmed that the instrument was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.Based on the conducted investigations of the device being subject to this complaint, no material or manufacturing related root cause could be determined.Taking into account the physicians description of the intervention and target lesion as well as the appearance of the target vessel in the angiographic material, the root cause is most likely related to the patients anatomy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO 2.25/22
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key9569397
Report Number1028232-2020-00114
Device Sequence Number374563
Product Code NIQ
UDI-Device Identifier07640130439085
UDI-Public7640130439085
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
P170030
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/04/2021
Device Model Number364499
Device Catalogue NumberSEE MODEL NO.
Device Lot Number03195869
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 01/08/2020
Supplement Date Received by Manufacturer03/11/2020
Initial Report FDA Received Date01/09/2020
Supplement Report FDA Received Date03/11/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-